HAIFA, Israel, Feb. 10, 2020 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a […]
FDA Acceptance of Libervant™ (diazepam) Buccal Film NDA for Management of Seizure ClustersPotential for First Oral Diazepam-Based Therapy for Population […]
Investigation underway into unexpected and inconsistent findings that may have negatively impacted results reported in TRILOGY 1Announces plans to seek […]
TORONTO, Feb. 10, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and […]
Previously Announced Strategic Review Remains Active and is Progressing; Decision Anticipated No Later Than June 30, 2020Base EBITDA from Continuing Operations […]